Gastroesophageal reflux (GERD) is a common medical condition that affects the digestive system, primarily the lower esophagus and stomach. It occurs when stomach contents, including stomach acid, flow backward into the esophagus, leading to a range of uncomfortable and potentially serious symptoms. Understanding GERD, its causes, symptoms, and treatment options is crucial for managing this condition effectively. GERD often presents as a chronic condition, necessitating ongoing management to prevent complications. Regular follow-up with a healthcare provider, symptom monitoring, and adjustments to treatment plans are essential components of effective long-term management.
The full spectrum of hyaluronans developed by ROELMI HPC – ExceptionHYAL® Relief – offers itself as a valid proposal in the treatment of symptoms related to gastroesophageal reflux, such as acid regurgitation, heartburn and indigestion, after meals or in subjects with symptoms related to reflux esophagitis. The activities of the hyaluronan spectrum contained in ExceptionHYAL® Relief were preliminarily tested in vitro and, subsequently, the effectiveness of the ingredient in relieving heartburn and acid reflux was confirmed by a clinical study, where it was simultaneously evaluated the reduction of the intake of self-medication antacid drugs. ExceptionHYAL® Relief creates a barrier effect by acting as a mechanical protector of the gastro-esophageal and oral tract, at the same time supporting epithelial regeneration by promoting the healing of micro-lesions caused by acid passage on the epithelium.